Subscribe to RSS
DOI: 10.1055/s-0037-1617810
Impfungen von Frühgeborenen
Vaccinations of preterm infantsPublication History
Publication Date:
12 January 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00034917/200402/lookinside/thumbnails/10-1055-s-0037-1617810_de-1.jpg)
Zusammenfassung
Die Frage des optimalen Zeitpunkts, um ein frühgeborenes Kind zu impfen, ist letztendlich nicht geklärt. Sicher ist, dass Frühgeborene einem erhöhten Risiko ausgesetzt sind, an einer schweren Infektionskrankheit zu erkranken. Zudem ist bekannt, dass die Ausbildung eines voll funktionsfähigen Immunsystems stark von dem Gestationsalter abhängig ist. Demgegenüber steht das Bestreben, den Kindern durch die Impfung eine wirksame und rechtzeitige Prophylaxe zu ermöglichen, d. h. Frühgeborene möglichst zeitnah nach Geburt zu immunisieren, da die Inzidenz verschiedener Krankheiten, wie z. B. invasiver Hib-Erkrankungen und Keuchhusten, bei Kindern im ersten Lebensjahr am höchsten ist. Diese Arbeit soll die grundlegenden Besonderheiten des sich entwickelnden Immunsystems darstellen und unter Berücksichtigung der empfohlenen Impfungen, eine praxisnahe Umsetzung ermöglichen.
Summary
When is the best time point to vaccinate a preterm infant? In the end this question is not cleared. Preterm infants are at an higher risk to aquire a severe infection. Besides this it is widely known, that the development of a functional immune system depends highly on the gestational age. On the other hand it must be the endeavor, to protect these infants with a effective prophylaxis in time, which means to vaccinate them short after birth, because of the fact, that in infants less than one year the highest incidence of some diseases, such as invasive Hib- and pertussis infections appears. This article demonstrates the main specialities of the developing immune system and should give a practical proposal, on consideration of the recommended schedule.
-
Literatur
- 1 Adenyi-Jones SA, Faden H. et al. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. Journal of Pediatrics 1992; 120: 686-9.
- 2 American Academy of Pediatrics. Report of the Committee on Infectious Diseases. 21st edn. Elk Grove Village, Illinois: The 1988 red book.;
- 3 Belson A, Reif S. et al. Immune response to Hepatitis B virus vaccine in 1 year-old preterm and term infants. Journal of Pediatric Gastroenterology and Nutrition 1996; 23: 252-5.
- 4 Bernbaum JC, Daft A. et al. Response of preterm infants to Diphtheria-Tetanus-Pertussis immunizations. Journal of Pediatrics 1985; 107: 184-8.
- 5 Bernbaum J, Anolik R. et al. Development of the premature infants host defense system and its relationship to routine immunisation. Clinics in Perionatology 1984; 11: 73-4.
- 6 Björkholm B, Granström M. et al. Influence of high titers of maternal antibody on the serologic response of infants to Diphtheria vaccination at three, five and twelve month of age. Pediatric Infectious Disease Journal 1995; 14: 846-50.
- 7 Chawareewong S. Immune response to Hepatitis B vaccine in premature neonates. Southeast Asian Journal Trp Med Public 1991; 22: 39-40.
- 8 Conway S, James J. et al. Immunisation of preterm babies. Journal of Infection 1993; 27: 143-50.
- 9 D’Angio CT, Maniscalco W. et al. Immunologic response of extremely premature infants to Tetanus, Haemophilus influenzae and Polio immunizations. Pediatrics 1995; 96: 18-22.
- 10 Del Canho R, Grosheide P. et al. Hepatitis B vaccination and preterm infants. Pediatric Infectious Disease Journal 1993; 12: 407-8.
- 11 Deutsche Gesellschaft für pädiatrische Infektiologie. Prophylaxe von bedrohlichen RSV-Erkrankungen durch Palivizumab. Stellungnahme. 2003: 1-6 http://www.dgpi.de/Publikation/PDFs/DGPIsynagisVO%c9S%c9%2005%202003fin.pdf
- 12 Esposito S, Faldella G. et al. Long term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in preterm infants. Vaccine 2002; 20 (23-24) 2928-32.
- 13 Fachinformation Synagis. Abbott GmbH; 1999
- 14 Faldella G, Alessandrini R. et al. The preterm infant’s antibody response to a combined Diphtheria, Tetanus, acellular Pertussis and hepatitis B vaccine. Vaccine 1998; 16: 1646-49.
- 15 Gerli R, Bertotto A. et al. Activation of cord T lymphocytes. I. Evidence for defective T cell mitogenesis induced through CD2 molecule. Journal of immunology 1989; 142: 2583-9.
- 16 Harvey J, Jones DB. et al. Differential expression of MHC- and macrophage-associated antigens in human and postnatal small intestine. Immunology 1990; 69: 409-15.
- 17 Hitzig WH. Die Entwicklung des Immunsystems beim Menschen. In: Wahn U, Seger R, Wahn V. Pädiatrische Allergologie und Immunologie, 2. Auflage. München: Fischer; 1994
- 18 Hohlfeld P, Forestier F. et al. Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mother and fetuses. Pediatric Infectious Disease Journal 1990; 9: 878-81.
- 19 Huang F, Lee P. et al. Hepatitis B vaccination in preterm infants. Archives of Disease in Childhood 1997; 77: F135-8.
- 20 Joint Committee on Immunisation and Vaccination. Immunisation against infectious disease. London: HM Stationery Office; 1988
- 21 Khalak R, Pichichero M. et al. Three year follow-up of vaccine response in extremely preterm infants. Pediatrics 1998; 101: 597-603.
- 22 Kim SC, Chung EK. et al. Immunogenicity of Hepatitis B vaccine in preterm infants. Pediatrics 1997; 99: 534-6.
- 23 Kristensen K, Gyhrs A. et al. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatric Infectious Disease Journal 1996; 15: 525-9.
- 24 Kumar A, Jauhari P. et al. Quantitation of T cells in venous blood of healthy neonates. Indian Journal of Pediatrics 1994; 61: 711-4.
- 25 Lau Y, Tam A. et al. Response of preterm infants to Hepatitis B vaccine. Journal of Pediatrics 1992; 121: 962-5.
- 26 Linder N, Vishne TH. et al. Heapatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols. Infection 2002; 30 (03) 136-9.
- 27 Munoz A, Salvador A. et al. Antibody response of low birth weight infants to Haemophilus influenzae type b Polyribosylribitol-phosphate-outer membrane protein conjugate vaccine. Pediatrics 1995; 96: 216-9.
- 28 Oliver AM, Sewell H. et al. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, DQ) in human fetal adrenal, pancreas, thyroid and gut. Transplant Proc 1989; 21: 651-2.
- 29 Pullan CR, Hull D. Routine immunisation of preterm infants. Archives of Disease in Childhood 1989; 64: 1438-41.
- 30 Ramsay ME, Miller E. et al. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Archives of Disease in Childhood 1995; 72: 230-2.
- 31 Reen JR. Activation and functional capacity of human neonatal CD4 T-cells. Vaccine 1998; 16 (14-15) 1401-8.
- 32 Remington JS, Klein JO. Infectious Diseases of the Fetus and Newborn Infant. 4. ed.. Philadelphia: WB Saunders; 1995
- 33 Schloesser RL, Fischer D. et al. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 1999; 103 (05) e60.
- 34 Shinefield H, Black S. et al. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pedaitr Inf Dis J 2002; 21 (03) 182-6.
- 35 Siegrist CA. Vaccination strategies for children with specific medical conditions: A paediatrician’s viewpoint. European Journal of Pediatrics 1997; 156: 899-904.
- 36 Smolen P, Bland R. et al. Antibody response to oral Polio vaccine in premature infants. Journal of Pediatrics 1983; 103: 917-9.
- 37 Washburn LK, O’Shea TM. et al. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. Journal of Pediatrics 1993; 123: 791-4.
- 38 Zepp F, Schmitt HJ. et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: Plain Haemophilus type b – PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. European Journal of Pediatrics 1997; 156: 18-24.
- 39 Zepp F, Knuf M. et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infection and Immunity 1996; 64: 4078-84.